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collagen matrix; signal transduction; wound repair WOUND REPAIR PROCESSES INVOLVE epithelialization, connective tissue deposition, and contraction (14) . Contraction is one of the important steps, inasmuch as it draws the margins of open wounds together. Forces generated by fibroblast cells that lead to wound contraction can be large enough to cause cosmetic scarring and even major body deformation. However, the mechanisms underlying contraction in wound repair remain poorly understood. Using cells grown in collagen gels and/or sheets, several groups estimated fibroblast contractility (3, 5, 6) . Fibroblast gel constriction was elicited by serum, eicosanoids, growth factors, glycoproteins, or phospholipids (7, 12, 17, 23, 29) . These methods had drawbacks, in that these responses were generally irreversible and provided only a qualitative estimate of the forces developed.
In 1995, we initially reported that fibroblast contraction was induced by 30% calf serum (CS) in NIH 3T3 fibroblast cells reconstituted into fibers by growing them in a three-dimensional collagen matrix (21) . Use of the fibroblast fiber enabled precise mechanical measurements of force, stiffness, and shortening velocity. CS elicited a maintained force that was readily reversed and reproducible on washout of CS. Additionally, the response was time and dose dependent (19, 21) . Cytochalasin D, a cytoskeleton inhibitor, abolished the contraction and confirmed that force was derived from the fibroblast cells (22) .
We characterized the intracellular signaling pathways underlying the CS-induced fibroblast contraction. However, CS is a mixture of physiological activating factors and additional factors, such as newly synthesized provisional matrix, that might localize at wound sites. Several contractile factors have also been suggested from experiments conducted with collagen gels, as described above. The nature of these factors and their mechanisms are not known with certainty. At wound repair sites, it is widely accepted that thromboxanes, including thromboxane A 2 (TxA 2 ), play central roles in the activation of blood coagulation and vascular smooth muscle contraction (1, 4, 10) . TxA 2 is one of the major products of arachidonic acid (AA) metabolism in platelets and activated macrophages. It is thought that it plays a key role in vascular homeostasis at the site of inflammation and injury (1, 16, 18) . These functions are reasonable and effective in the initial stage of wound repair. It is also reported that TxA 2 receptor stimulation activated PKC and/or Rho kinase mediated by inositol trisphosphate-associated intracellular Ca 2ϩ increases (33) . However, the critical effect of these kinases on the TxA 2 -induced fibroblast contraction has not been understood. Because TxA 2 occurs at the wound site after the initial steps, we hypothesized that TxA 2 might play a role in later stages.
We found that U-46619, a TxA 2 analog, could elicit a significant contraction and investigated the intracellular signaling pathways involved. Interestingly, TxA 2 does not appear to be one of the activating factors in CS but works in a parallel and additive fashion.
METHODS
Cell culture and fibroblast fiber preparation. NIH 3T3 fibroblast fibers were subcultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% CS, 100 U/ml penicillin, and 100 g/ml streptomycin. Cells were grown on 100-mm dishes in 5% CO 2-95% air at 37°C. Cells were propagated using 0.04% trypsin and 0.02% EDTA in phosphatebuffered saline, pH 7.4, at a 1:3 split ratio. Fibroblast fibers were prepared according to Obara et al. (21) . Rat tail collagen solution was neutralized with 0.1 N NaOH in an ice bath. Dispersed cells were suspended in a solution containing 2 ϫ 10 6 cells/ml and 0.5 mg/ml collagen in DMEM. A cell suspension of 2 ml was poured into a specially designed mold (0.8 cm ϫ 5 cm ϫ 0.5 cm deep), which was cut into a layer of silicone rubber in a 100-mm dish and placed in a CO 2 incubator at 37°C. After 2 h, an additional 0.5 ml of DMEM was added to each well. The fibroblast fiber preparations were incubated for 2-4 days.
Measurement of isometric force development. NIH 3T3 fibroblast fibers were cut into 5-mm pieces and mounted between glass posts with cyanoacrylate glue. One post was fixed, and the opposite side was connected to a silicone strain gauge force transducer (model AME801, SensoNor, Horten, Norway). The fibers were bathed in MOPS-buffered physiological salt solution (MOPS-PSS) containing (mM) 140 NaCl, 4. (8) . Fura 2-AM was prepared as a stock solution of 1 mM dye in DMSO. The fura 2 loading solution consisted of 3 M fura 2-AM, 0.015% Pluronic F-127, and 0.5% DMSO in MOPS-PSS; additionally, the solution was sonicated for Ն5 min to facilitate dispersion of the fura 2-AM. Fibroblast fibers were incubated in this solution at room temperature for 3 h. Subsequently, fibroblast fibers were rinsed in MOPS-PSS for 15 min to remove extracellular and nonhydrolyzed fura 2-AM. A segment (ϳ2 mm) of the fura 2-loaded fibroblast fiber was placed in a glass-bottom culture dish and covered with nylon mesh, which maintained the fiber in an isometric manner. The fiber was placed in a chamber with a total volume of 500 l and perfused (5 ml/min) with MOPS-PSS, while a temperature of 37°C was maintained. [ 
,NЈ -tetraacetic acid (fura 2) and fura 2 penta-AM (fura 2-AM) from Molecular Probes, phosphatidic acid (PA), lyso-PA, platelet-activating factor (PAF), lyso-PAF, sphingosin-1-phosphate (sphingosine), AA, histamine, U-46619, cytochalasin D, cyclopiazonic acid (CPA), calphostin C, ML-7, W-7, Gö-6976, and rottlerin from Sigma Chemical (St. Louis, MO), SQ-29548 from Cayman Chemical (Ann Arbor, MI), and KN-62 from Calbiochem (San Diego, CA).
was kindly provided by Mitsubishi Pharma (Osaka, Japan). Calphostin C, KN-62, and ML-7 were dissolved in DMSO as stock solutions. U-46619 was dissolved in ethanol as a stock solution. Each DMSO and ethanol concentration in the bathing medium was Ͻ0.05% and had no effect on mechanical responses. The remaining agents were dissolved in deionized water. CaCl 2 was replaced with 10 mM EGTA (pH 7.4) in Ca 2ϩ -free MOPS-PSS. Data analysis. Values are means Ϯ SE. Group data were compared with a one-way analysis of variance. Bonferroni's method was employed to determine the level of significance of differences between groups. P Ͻ 0.05 was considered statistically significant.
RESULTS

Agents that contract NIH 3T3 fibroblast fibers.
We studied a variety of putative agonists for contractile activity (Fig. 1) . The fibroblast fibers were mounted on a specially designed isometric force measurement system with 50 N resting tension. The sustained force developed in response to 30% CS was used as a control response. Maximal force measured 15 min after the stimulation was 136.2 Ϯ 7.4 N (n ϭ 5). Changes in [Ca 2ϩ ] i were also measured using a fura 2-loaded fiber segment from the same fibroblast fiber. For the [Ca 2ϩ ] i measurements, resting tension, reagent concentration, and time course were matched with those used for force measurement. Treatment with 30% CS induced a transient increase in [Ca 2ϩ ] i . The maximal increase was detected ϳ2 min after the treatment and averaged 192.6 Ϯ 11.0 nM (n ϭ 5).
Several known contractile agonists were tested, and force and [Ca 2ϩ ] i responses were measured. Treatment for 15 min with the phospholipids 10 M PA, 10 M lyso-PA, 3 M PAF, 3 M lyso-PAF, and 10 M sphingosine did not induce significant increases (Ͻ20% of the CS-induced response). These concentrations were chosen to be in the near-maximal range based on the literature. (Fig. 2B ). The maximal response was 165.3 Ϯ 7.6 nM (n ϭ 7). After the peak, [Ca 2ϩ ] i declined to the resting level (97.0 Ϯ 4.6 nM, n ϭ 7) at 7 min after U-46619 addition. During the transient increase in [Ca 2ϩ ] i , isometric force increased ( Fig. 2A) but was maintained. The maximal level was detected 12-15 min after U-46619 treatment. The time courses of [Ca 2ϩ ] i and force development were similar to those observed with 30% CS stimulation (20) .
The increases in force and [Ca 2ϩ ] i were dependent on U-46619 concentration (Fig. 3A) . Significant increases were detected at 3 nM U-46619, and a maximal response was evident at 100 nM U-46619. EC 50 values were 10.0 and 11.0 nM, respectively. U-46619-induced force and [Ca 2ϩ ] i responses were suppressed by pretreatment with 1 M SQ-29548 (4), a specific TxA 2 receptor antagonist (Fig. 3B) . In the presence of SQ-29548, 100 nM U-46619-induced responses were 8.4 Ϯ 1.3 N and 81.6 Ϯ 2.2 nM (n ϭ 5), respectively. To confirm that the U-46619-induced force was derived from fibroblast cell contraction, the cytoskeleton inhibitor cytochalasin D was used. Treatment with 10 M cytochalasin D for 10 min reduced resting force from 52.0 Ϯ 0.9 to 45.6 Ϯ 0.8 N (n ϭ 5). Addition of 100 nM U-46619 induced transient increases in [Ca 2ϩ ] i identical to the normal response; however, the force response disappeared. The value was 46.2 Ϯ 0.7 N (n ϭ 5) 15 min after introduction of U-46619.
Intracellular Ca 2ϩ dependence of NIH 3T3 fibroblast fiber contraction. To delimit the sources of Ca 2ϩ , we first inhibited Ca 2ϩ influx from the extracellular medium using Ca 2ϩ -free MOPS-PSS (Fig. 4) . Pretreatment with Ca 2ϩ -free MOPS-PSS for 5 min did not influence resting levels of [Ca 2ϩ ] i . However, the transient increase in [Ca 2ϩ ] i in response to 100 nM U-46619 was suppressed. Ca 2ϩ -free MOPS-PSS slightly reduced the resting force levels, and the sustained increase in force in response to U-46619 was inhibited (13.0 Ϯ 2.0 N, n ϭ 5); furthermore, the rate of force development was reduced. Similar results were detected in the presence of the Ca 2ϩ channel inhibitor nifedipine (3 M, 10-min preincubation; data not shown).
The sarco-and endoplasmic reticulum Ca 2ϩ -ATPase (SERCA) inhibitor CPA was used to assess the role of intracellular Ca 2ϩ stores ( tissues, Ͼ85% of the normal response was maintained after pretreatment with the maximal concentration of these inhibitors. TxA 2 receptor is known to enhance the activity of PKC. However, the isoform(s) of PKC involved has not been characterized. In this study, we used three types of PKC inhibitors (general, Ca 2ϩ -dependent, and Ca 2ϩ -independent) to narrow the possible isoforms. As shown in Fig. 7 , 1 M calphostin C (11) did not affect basal levels of force or [Ca 2ϩ ] i . However, the U-46619-induced increase in force development was significantly inhibited without affecting the transient [Ca 2ϩ ] i response. The responses to 100 nM U-46619 in the presence of calphostin C were 78.2 Ϯ 2.6 N and 164.0 Ϯ 6.0 nM (n ϭ 5), which were 46.8 Ϯ 3.1% and 96.3 Ϯ 5.4%, respectively, of the control responses in the absence of calphostin C. As in our previous study, calphostin C had little effect on the CS-induced contraction. Neither Gö-6976 (15), a Ca 2ϩ -dependent PKC inhibitor, nor rottlerin (9), a Ca 2ϩ -independent PKC inhibitor, had any effects on CS-induced contractures, similar to calphostin C. Importantly, Gö-6976, but not rottlerin, inhibited the U-46619-induced force. These data are summarized in Fig. 8 .
To assess the potential involvement of Rho kinase signaling pathways in the U-46619 contracture, we used the Rho kinase inhibitor Y-27632 (Fig. 9) . Treatment with 1 M Y-27632 for 10 min slightly reduced resting levels from 51.2 Ϯ 1.9 to 43.4 Ϯ 3.9 N (n ϭ 5). During the treatment, [Ca 2ϩ ] i was unaltered. Stimulation with 100 nM U-46619 induced a transient increase in [Ca 2ϩ ] i ; however, the sustained increase in force development was suppressed. With Y-27632 pretreatment, the U-46619-induced responses were 170.8 Ϯ 6.0 nM and 40.8 Ϯ 4.5 N (n ϭ 5), respectively.
Relation between CS-and U-46619-induced responses in NIH 3T3 fibroblast fibers. In light of our previous results, we investigated the degree to which the responses to CS could be attributable to U-46619-like activation of TxA 2 receptors. From these results, it appeared that the intracellular signaling pathway in U-46619 stimulation was different from that in CS stimulation. To confirm that the signaling pathways for U-46619 and CS were different, we measured effects on contractile responses using combinations of both stimulators. We first measured the sustained force elicited by 100 nM U-46619 or 30% CS (Fig. 10A) . After the fibers were rinsed, the 30% CS treatment was repeated (143.4 Ϯ 4.0 N, n ϭ 5). Then 100 nM U-46619 was added, and force was significantly increased to 168.2 Ϯ 3.9 N (n ϭ 5). The identical strategy was used to measure the [Ca 2ϩ ] i response (Fig. 10B ). Because treatment with U-46619 or CS elicited only transient increases in [Ca 2ϩ ] i , 100 nM U-46619 and 30% CS were introduced simultaneously. In this case, the peak of the transient increase was significantly elevated (228.8 Ϯ 4.6 nM, n ϭ 5) from each respective U-46619 peak level (168.8 Ϯ 5.2 and 196.8 Ϯ 3.8 nM, respectively, n ϭ 5).
To confirm that the CS-induced response was not mediated by the TxA 2 receptor, we pretreated fibers with the TxA 2 receptor inhibitor SQ-29548 (1 M; Fig.  11 ). CS-induced increases in [Ca 2ϩ ] i and force were not influenced by this treatment. After pretreatment with SQ-29548, CS-induced force and [Ca 2ϩ ] i were 100.8 Ϯ 11.6% and 96.5 Ϯ 7.1%, respectively, of a single treatment of CS (n ϭ 5).
DISCUSSION
We previously reported that the presence of CS elicited a sustained contraction of the fibroblast fiber reconstituted after subculture of NIH 3T3 fibroblast cells (20, 21) . Because CS contains various substances, several candidates responsible for the contractile response were investigated, and a thromboxane analog, U-46619, was found to elicit a sustained contraction with a transient increase in [Ca 2ϩ ] i in the fibroblast fiber. These responses to U-46619 were suppressed in the presence of SQ-29548 (4), a TxA 2 receptor antagonist, indicating that the responses of the fibroblast fiber to U-46619 are mediated via activation of the specific receptor for TxA 2 .
Phospholipids and several molecules related to the signal transduction were reported to exert contractile effects measured by a morphological observation using fibroblast cells in collagen gels (7, 13) . Furthermore, Ridley and Hall (25) reported that lyso-PA induced stress fiber formation in the fibroblast cells. However, in our NIH 3T3 fibroblast fibers, these substances, with the exception of U-46619, did not increase isometric force. It is possible that the receptor phenotype or cellular enzymes may differ under different culture conditions. Alternatively, the change in cell shape observed in the collagen gels may be caused by small and chronic forces below our level of detectability and may not reflect the isometric force development observed in the fibroblast fibers.
Most reagents had no influence on the basal tension of the fibroblast fiber; however, a TxA 2 analog, U-46619, significantly increased force to ϳ65% of the CS-induced response (Fig. 1) . To our knowledge, this is the first report of isometric force development in response to a single physiological molecule in fibroblast fibers. It is widely accepted that TxA 2 is localized in wound areas at initial stages and functions as an activator of the blood coagulation system and smooth muscle contraction (2, 27) . TxA 2 released by macrophages and leukocytes during inflammation is also an important factor associated with wound repair. Inasmuch as a low concentration (100 nM) of U-46619 induced maximal force development, we hypothesized that TxA 2 may play a specific role in fibroblast contraction in wound repair.
We confirmed that treatment with Ca 2ϩ -free MOPS-PSS or the Ca 2ϩ channel inhibitor nifedipine inhibited the CS-induced [Ca 2ϩ ] i response, but not force devel- opment (20) . In contrast, U-46619-induced increases in [Ca 2ϩ ] i and force were inhibited under these conditions (Fig. 4) . SERCA inhibition with CPA or thapsigargin also significantly inhibited the U-46619-induced (Fig.  5 ) and CS-induced responses. Thus Ca 2ϩ mobilization for the CS-and U-46619-induced fibroblast contractions was not identical.
In smooth muscle cells, it is widely accepted that [Ca 2ϩ ] i regulates contractile responses associated with CaM-, Ca 2ϩ /CaM kinase-, and MLCK-dependent pathways (28) . Inhibitors of these pathways did not affect the U-46619-induced responses, similar to our previously reported CS-induced responses. However, inhibition by Y-27632 (32) suggested that the Rho kinase pathway was essential for CS-and U-46619-induced contraction.
Both types of stimulation were also characterized by similar time courses. However, the intracellular signaling pathways did not completely overlap. The TxA 2 receptor antagonist SQ-29548 (4) blocked the U-46619 contraction but did not affect CS-induced responses. Moreover, addition of 100 nM U-46619 enhanced the maximal force of a 30% CS contraction (Fig. 11) . The additivity of U-46619 and CS is of interest, suggesting the existence of multiple, independent pathways. In addition, inhibition of another key enzyme of the Ca 2ϩ -signaling pathway, PKC, led to a decrease in the U-46619-induced contraction without affecting the [Ca 2ϩ ] i response (Fig. 7) . These findings suggested that the U-46619-induced contraction may involve PKC downstream from [Ca 2ϩ ] i signals. Moreover, our studies showed that Gö-6976, but not rottlerin, blunted the U-46619-induced contraction, suggesting that a Ca 2ϩ -dependent PKC was involved. In contrast, our previous study indicated that the CS-induced contraction does not involve PKC (20) . These data indicate that TxA 2 -induced contraction does not correspond with CS-induced contraction.
Using Ca 2ϩ -free PSS and/or CPA pretreatments, we previously showed that an increase in Ca 2ϩ derived 2 -induced responses do not appear to be involved in the CS-induced contraction, we hypothesize that TxA 2 functions not only as a blood coagulation factor at the initial stage of wound repair but also as a contractile factor for fibroblasts in later repair processes.
